Review

Exploring the landscape of targetable alterations in patients with glioblastoma.

E. Aquilanti M. Touat P. French A. Iavarone D. Capper Marjolein Geurts Rifaquat Rahman R. Verhaak M. Preusser M. J. van den Bent Patrick Y. Wen

Aug 2026 · Nature Reviews Clinical Oncology · 0 citations · 198 references

Medicine

TL;DR

The therapeutic landscape of targeted therapies in glioblastomas is summarized, spanning major target classes including receptor tyrosine kinases, intracellular signalling proteins, cell-cycle dysregulation and synthetic-lethal vulnerabilities and emerging strategies targeting genome integrity and telomeres, epigenetic modulators, and tumour-neural circuitry are examined.

DOI PubMed Semantic Scholar

View source

Similar papers

Review Open access Aug 2026

Pathway dysregulation and therapeutic resistance in glioblastoma: molecular mechanisms and emerging therapeutic targets

A narrative review summarizes the major signaling pathways implicated in GBM pathogenesis, including EGFR, PI3K/AKT/mTOR, Wnt, and TGF-β signaling, while also discussing emerging therapeutic targets such as FGFR3–TACC3 fusions, regorafenib, and natural killer cell-based immunotherapy.

William Li, Jia-Ming Chen, Yi-Chao Ma · Future Science OA · 0 citations

Review Open access Jul 2026

Nanomedicine for Glioblastoma Therapy: Novel Insights and Future Perspectives.

This review systematically summarizes recent advances in nanomedicine enabled GBM therapy from four interrelated perspectives: the optimization of nanomaterial properties, the development of goal-oriented targeting strategies, the rationalization of delivery routes, and the engineering of smart stimuli-responsive nano-...

Yu Guo, Keqiang Lu, Wenmiao Luo et al. · Wiley Interdisciplinary Revi... · 1 citation

Review Aug 2026

Targeting glioblastoma epigenetics: mechanisms, microenvironmental interplay, and therapeutic potential.

The present review explores the complex epigenetic mechanisms such as DNA methylation, histone modification and RNA editing that drive GBM progression, shape the tumor microenvironment and facilitate immune evasion and highlights the therapeutic potential of targeting these epigenetic vulnerabilities through inhibitors...

S. Raut, L. Bhatt · Neuroscience · 0 citations

Review Open access Jul 2026

Mechanisms of Therapeutic Resistance and Recent Advances in Glioblastoma Treatment

The mechanisms through which glioblastoma is initiated, localized, and eludes therapy responses are summarized and an update is provided on recent advances made within this therapeutic space to overcome GBM‐mediated immunosuppression.

Emerson Achari, Farah Ahmady-Nield, Amit Sharma et al. · Immunology and Cell Biology · 0 citations

Review Aug 2026

Drug resistance in breast cancer brain metastasis: mechanisms and therapeutic strategies.

This comprehensive review highlights BMBC resistance mechanisms, drawing from preclinical models, clinical studies, and genomic analyses, and highlights the potential for personalized, multi-targeted approaches to improve patient outcomes in BMBC.

Paromita Sarker, Shreyas S. Rao · Biochimica et biophysica act... · 0 citations

Review Open access Jul 2026

Emerging nanoparticles for glioblastoma: Engineering precision across the blood-brain barrier

This review critically explore a diverse variety of advanced nanocarrier platforms designed for anti-proliferative, radiosensitizing and immunomodulatory interventions and highlights how rational nanoparticle design can shift GBM management toward targeted, multimodal precision therapy, offering renewed hope against on...

Huzaifa Shoaib, Arfa Khan · NUST Journal of Natural Scie... · 0 citations